![](https://cdn.koreabiomed.com/news/thumbnail/202408/24799_25775_83_v150.jpg)
Some drugmakers fared better than others despite medical turmoil in H1
Despite the deteriorating business environment due to the turmoil caused by the government’s increase of the medical school enrollment quota, Hanmi Pharmaceutical, Boryung, and HK inno.N maintained sales growth in the first half of this year thanks to …